Be Clinical pulls in ₹21 Cr seed extension led by Sauce VC
The D2C skincare brand raised approximately $2.2 million in a seed extension round led by Sauce to fuel further growth.
Indian D2C skincare brand Be Clinical has closed a seed extension round of ₹21 crore (approximately $2.2 million), with the round led by Sauce. The funding marks a continuation of the company's early-stage capital-raising as it looks to scale its direct-to-consumer skincare business.
The company operates in India's D2C skincare segment, selling products directly to consumers rather than through traditional retail intermediaries. Details on the specific use of proceeds were not disclosed at the time of announcement.
Sauce, which led the round, is an investor focused on consumer and D2C brands. The seed extension structure suggests Be Clinical had previously raised an initial seed tranche before returning to investors for additional capital ahead of a larger Series A raise.
The D2C skincare category in India has attracted significant investor interest in recent years, with a number of brands competing for consumer attention across digital channels. Be Clinical's seed extension signals continued investor appetite for early-stage bets in the space.
Founders
- Fiona FrieMedical Director
Press
About the Company
D2C skincare brand Be Clinical has raised ₹21 Cr (about $2.2 Mn) in its seed extension round led by Sauce.
San Ramon & San Francisco Bay Area medical aesthetics. Injectables, lasers, body contouring, hormone & wellness — advanced treatments designed around you.